Organization Overview
Alternative names
alemtuzumab (campath) (3 trials)
bendamustine (treanda) (3 trials)
bortezomib (velcade) (1 trial)
brentuximab vedotin (adcetris) (3 trials)
cisplatin (platinol) (1 trial)
cytarabine (cytosar-u) (3 trials)
doxorubicin (Doxil) (5 trials)
etoposide (vepesid) (3 trials)
gemcitabine (gemzar) (2 trials)
hydrocortisone (solu-cortef) (1 trial)
Aggression (Phase 2)
Graft vs Host Disease (Phase 2)
Hodgkin Disease (Phase 2)
Leukemia (Phase 2)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)
Leukemia, Lymphoid (Phase 2)
Lymphoma (Phase 2)
Lymphoma, B-Cell (Phase 2)
Lymphoma, B-Cell, Marginal Zone (Phase 2)
Lymphoma, Follicular (Phase 2)
Lymphoma, Large B-Cell, Diffuse (Phase 2)
Lymphoma, Mantle-Cell (Phase 2)
Lymphoma, Non-Hodgkin (Phase 2)
Neoplasms (Phase 2)